News
08.15.22

When My Frustrated Staff Said, “We Need Another Option,” I Found OSRX®. We’ve Been Happily Together for Five Years.

By Dr. Sydney L. Tyson, MD, MPH

Dr. Sydney L. Tyson founded Eye Associates & SurgiCenter of Vineland (N.J.) in 1999, a medical and surgical ophthalmology practice that has expanded to six offices serving southern New Jersey and greater Philadelphia, Pa. With a medical degree from Harvard Medical School and an advanced degree from Harvard School of Public Health, Dr. Tyson has built a multi-specialty practice focused on diagnosing and treating all types of eye diseases, conditions and visual challenges for patients of all ages. Beyond primary care, Eye Associates provides dropless IV free custom cataract surgery, bladeless custom LASIK, minimally invasive glaucoma surgery (MIGS) and more.

I started prescribing compounded formulations of eye medications for my patients many years ago. I’ve tried different compounding pharmacies and formulations to meet the needs of my patients who require specially- compounded drugs, but never found a compounding pharmacy with the right blend of customer service, convenience, and quality.  Honestly, I simply got tired of the ball being dropped and my patients getting frustrated. Equally important, my staff was confronted with a variety of issues like our specific patient prescriptions often being delivered late or not appropriately filled. They said, “This is enough; we need another option.”

It’s very simple: I, like every doctor, want to make work enjoyable for my staff and assure my patients receive appropriate treatment and achieve the best possible health outcomes.

I had known Dr. Damien Goldberg (co-founder, Ocular Science®, an affiliate of PCAB-accredited 503A compounding pharmacy OSRX®) and Dr. Francis Mah (co-founder, Ocular Science) for quite a while so I’d heard they were involved with a new compounding pharmacy that was offering superior customer service. I did my homework, met Anthony Sampietro – a straight-shooting CEO who listens to doctors and wants to make our lives easier – and I’ve partnered with OSRX to compound drugs for my patients ever since.

Click Here to Request More Information From an OSRX Representative

They provide combinations you can’t normally find in one bottle. Sure, it’s convenient, but efficacy is another vital benefit. When I combine a non-steroidal with a steroid and antibiotic, the foreign body sensation and photo sensitivity that patients can experience after LASIK is significantly reduced and they don’t have to administer three different drops. For cataract surgery, we use the Pred+Brom combination quite a bit, especially for our MIGS patients because we don’t like to use steroids for longer term for patients who might be steroid responders. We also use intracameral Dex+Moxi to get ahead of the inflammatory cascade and provide sound endophthalmitis prophylaxis. OSRX performs perfectly in this niche by providing simple options.

Another factor is clarity around insurance, which used to lead patients to worry about donut hole issues and coupons. It also used to lead to my staff making unwanted phone calls and wasting time. The streamlined payment process for patients who utilize drugs compounded by OSRX is another added benefit.  When doctors have a wish-list of patient-specific formulations, and OSRX says, “Hey, we can compound that for you,” … that’s a big deal and the beauty of compounding. 

 

Professional Disclosure: Dr. Sydney Tyson is on the board for directors and a medical advisory board member for Ocular Science® (an OSRX affiliate) and has a financial interest in the company.

OSRX operates in full compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. 503A compounding pharmacies are not required to comply with cGMP requirements but can be inspected by FDA. References available upon request.

Click here to view potential contraindications.